Advances in celiac disease

Current Opinion in Gastroenterology

Volumn 27, Issue 2, 2011, Pages 112-118

  Moore, Joanna K ^a   West, Susanna R A ^a   Robins, Gerry ^a  

^a YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

celiac disease; gluten free diet; serology; single nucleotide polymorphisms

Indexed keywords

CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GALECTIN; GALECTIN 10; UNCLASSIFIED DRUG;

CELIAC DISEASE; DISEASE ASSOCIATION; ENDOCYTOSCOPY; FOLLOW UP; GENETIC SUSCEPTIBILITY; GLUTEN FREE DIET; HUMAN; INTESTINE BIOPSY; INTESTINE MUCOSA PERMEABILITY; PATIENT MONITORING; PHENOTYPE; PREVALENCE; QUANTITATIVE ANALYSIS; REVIEW; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, CD; CAPILLARY PERMEABILITY; CELIAC DISEASE; CHOLERA TOXIN; CYTOKINES; DIET, GLUTEN-FREE; GALECTINS; HUMANS; INTESTINE, SMALL; PERMEABILITY;

EID: 79951682675     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283423f0a     Document Type: Review

References (42)

1. Vilppula A, Kaukinen K, Louostarinen L, et al. Increasing prevalence and high incidence of coeliac disease in elderly people: a population-based study. BMC Gastroenterol 2009; 9:49; doi: 10.1186/1471-230X-9-49.
2. Van der Windt D, Jellema P, Mulder C, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA 2010; 303:1738-1746.
3. Dahlbom I, Korponay-Szabo I, Kovacs J, et al. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr 2010; 50:140-146.
4. Vivas S, de Morales J. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol 2009; 15:4775-4780.
5. Rostami K, Mulder CJ, Stapel S, et al. Autoantibodies and histogenesis of celiac disease. Rom J Gastroenterol 2003; 12:101-106. (Pubitemid 36827750)
6. Dutta A, Chacko A, Avinash B. Suboptimal performance of IgG antitissue transglutaminase in the diagnosis of celiac disease in a tropical country. Dig Dis Sci 2010; 55:698-702.
7. Bansal A, Lindemann M, Ramsperger V, et al. Celiac Gp antibody assay for the detection of autoantibodies in celiac disease. Ann N Y Acad Sci 2009; 1173:36-40.
8. Lewis NR, Scott BB. Meta-analysis of deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2009; 31:73-81.
9. Volta U, Granito A, Parisi C, et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease. J Clin Gastroenterol 2010; 44:186-190.
10. Salmi TT, Collin P, Reunala T, et al. Diagnostic methods beyond conventional histology in coeliac disease diagnosis. Digestive Liver Dis 2010; 42:28-32.
11. Matysiak-Budnik T, Coron E, Mosnier JF, et al. In vivo real-time imaging of human duodenal mucosal structures in celiac disease using endocytoscopy. Endoscopy 2010; 42:191-196.
12. Pohl H, Rosch T, Tanczos B, et al. Endocytoscopy for the detection of microstructural features in adult patients with celiac sprue: a prospective, blinded endocytoscopy-conventional histology correlation study. Gastrointest Endosc 2009; 70:933-941.
13. Dubois PC, van Heel DA. Translational mini-review series on the immunogenetics of gut disease: immunogenetics of celiac disease. Clin Exp Immunol 2008; 2:162-173. (Pubitemid 351989169)
14. Van Heel DA, Franke L, Hunt KA, et al. A genome-wide association study for celiac disease identifies risk variants in the region harbouring IL2 and IL21. Nat Genet 2007; 39:827-829. (Pubitemid 47014494)
15. Trynka G, Zhernakova A, Romanos J, et al. Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-KB signaling. Gut 2009; 58:1078-1083.
16. Dema B, Martinez A, Fernandez-Arquero M, et al. Association of IL18RAP and CCR3 with coeliac disease in the Spanish population. J Med Genet 2009; 46:617-619.
17. Dubois P, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010; 42:295-301.
18. Garner CP, Murray JA, Ding YC, et al. Replication of celiac disease UK genome-wide association study results in a US population. Hum Mol Genet 2009; 18:4219-4225.
19. Pietzak M, Scholfield TC, Mcginniss M, et al. Stratifying risk for celiac disease in a large at risk United States population by using HLA alleles. Clin Gastroenterol Hepatol 2009; 7:966-971.
20. Castellanos-Rubio A, Santin I, Irastorza I, et al. A regulatory single nucleotide polymorphism in the ubiquitin D gene associated with celiac disease. Hum Immunol 2010; 71:96-99.
21. Gudjonsdottir AH, Nilsson S, Naluai A, et al. Association between genotypes and phenotypes in coeliac disease. J Pediatr Gastroenterol Nutr 2009; 49:165-169.
22. Maiuri L, Luciani A, Villela VR, et al. Lysosomal accumulation of gliadin p31 -peptide induces oxidative stress and tissue transglutaminase-mediated PPARg downregulation in intestinal epithelial cells and coeliac mucosa. Gut 2010; 59:311-319.
23. Manavalan JS, Hernandez L, Shah JG, et al. Serum cytokine elevations in celiac disease: association with disease presentation. Hum Immunol 2010; 71:50-57.
24. De Re V, Simula MP, Cannizzaro R, et al. Galectin-10, eosinophils, and celiac disease. Ann N Y Acad Sci 2009; 1173:357-364.
25. Oaks MK, Hallett KM. A soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 2000; 164:5015-5018. (Pubitemid 30305171)
26. Saverino D, Brizzolara R, Simone R, et al. Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation. Clin Immunol 2007; 123:190-198. (Pubitemid 46590071)
27. Simone R, Brizzolara R, Chiappori A, et al. A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury. Int Immunol 2009; 21:1037-1045.
28. Myrsky E, Caja S, Simon-Vecsei Z, et al. Coeliac disease IgA modulates intestinal vascular permeability in vitro through the activity of transglutaminase and RhoA. Cell Mol Life Sci 2009; 66:3375-3385.
29. Solid LM, Khosia C. Future therapeutic options for celiac disease. N Engl J Med 2007; 2:140-147.
30. Fasano A, Not T, Wang W, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000; 355:1518-1519. (Pubitemid 30237361)
31. Lammers KM, Lu R, Brownley J, et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to chemo receptor CXCR3. Gastroenterology 2008; 135:194-204.
32. Duerksen DR, Wilhelm-Boyes C, Veitch R, et al. A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten free diet. Dig Dis Sci 2010; 55:1026-1031.
33. Drago S, El Asmar R, Di Pierro M, et al. Gliadin, zonulin and gut permeability: effects on celiac and nonceliac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol 2006; 41:401-419.
34. Zandonadi RP, Botelho RBA, Araujo WMC, et al. Psyllium as a substitute for gluten in bread. J Am Dietetic Assoc 2009; 109:1781-1784.
35. Tye-Din JA, Anderson RP, French RA, et al. The effects of AVL300 predigestion of gluten on immune response and symptoms in celiac disease in vivo. Clin Immunol 2010; 134:289-295.
36. Kapoerchan VV, Wiesner M, Hillaert U, et al. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule. Mol Immunol 2010; 47:1091-1097.
37. Liang L, Pinier M, Leroux JC, Subirade M. Interaction of a-gliadin with polyanions: design considerations for sequestrants used in supportive treatment of celiac disease. Biopolymers 2009; 95:418-428.
38. FrisulloG, Nociti V, Iorio R, et al. T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity. Clin Exp Immunol 2009; 158:106-114.
39. Derikx JPM, Vreugdenhil ACE, Van den Neucker AM, et al. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 2009; 43:727-733.
40. Liu H, Brais R, Lavergne-Slove A, et al. Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease. Gut 2010; 59:452-460.
41. Birkenfield S, Dreiher J, Weitzman D, Cohen AD. Coeliac disease associated with psoriasis. Br J Dermatol 2009; 161:1331-1334.
42. Glas J, Stallhofer J, Ripke S, et al. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am J Gastroenterol 2009; 104:1737-1744.